Journal Reading - Alergi

Embed Size (px)

Citation preview

  • 7/30/2019 Journal Reading - Alergi

    1/34

    Journal Reading of Allergyand Immunology Sub Dept

    Patient-OrientedSCORAD (PO-

    SCORAD): a new self-

    assessment scale in

    atopic dermatitis

    validated in Europe

    Stalder et al

    Allergy 66(2011):1114-1121

  • 7/30/2019 Journal Reading - Alergi

    2/34

    IntroductionChronic/relapsing

    pruritic inflammatoryskin disease

    Dry skin

    Significant impactQOL

    Public health cost

    Industrialized CountriesChildren : 10 20%

    Adults : 1 3%

    ATOPICDERMATITIS

  • 7/30/2019 Journal Reading - Alergi

    3/34

    Introduction

    Severity +management

    ETFAD (1992)

    SCORAD

    (efficacy tx)

    CharacteristicAD is not

    similar each

    course

    Assessmentby doctorinsufficient

  • 7/30/2019 Journal Reading - Alergi

    4/34

    Introduction

    SELFASSESSMENT

    SCALE

    Bettermonitoring

    An effectivecommunication

    tool

    Require greaterpatients

    involvement

    SA-EASI ratingscale, Skin

    Detective scale,ADQ, POEM

    scale

  • 7/30/2019 Journal Reading - Alergi

    5/34

    Introduction

    Subjective

    symptoms

    Objectivesymptoms

    PO-SCORAD

    SAS by ETFAD

    To validate this scale in a large European population of adults and children

    To assess the consistency between SCORAD PO-SCORAD

    To confirm PO-SCORAD is quick and easy

  • 7/30/2019 Journal Reading - Alergi

    6/34

    Patients and MethodsProspective,

    observationalstudy

    Feb 09 Jan2010

    Belgium,Denmark,

    Finland, France,Germany, Italy,

    the Netherlands,Sweden,

    Switzerland

    The protocol was

    validated byindependentscientific (ETFAD)

    Informed Consent

  • 7/30/2019 Journal Reading - Alergi

    7/34

    Subjects and Procedures

    Adults (> 18 yo) children (< 18 yo)

    understand and complete thePO-SCORAD questionnaire

    Disease severity : D0 and D28

    Evaluation based on the same items, objective and subjective symptoms:1. Surface area of skin affected by eczema in the last 3 days2. Dryness of the skin without eczema3. Evaluation of the severity of the eczema over the last 3 days (redness of

    skin affected by eczema, swelling, oozing/crust, scratching and thickening),

    4. Pruritus and sleep loss

  • 7/30/2019 Journal Reading - Alergi

    8/34

    Evaluation Criteria and plan ofAnalysis

    Consistency between PO-SCORAD and SCORAD,

    coefficient correlation > 0.7 with a lower limit of CI 95% >

    0.65

    Main criteria : correlation between PO-SCORAD and SCORADindexes at D0 for overall population

    The consistency between 2 scales was evaluated :

    Correlation between 2 scales indexes at D28 for all

    populationD28, time period D0 D28 > 21 days and 21 days and < 35 days

    The same correlations were also determined for adults

    and children subgroups

  • 7/30/2019 Journal Reading - Alergi

    9/34

    Statistical Analysis SAS software (9.13 ver, pack 4, SAS Institute Inc., Cary, NC,

    USA)

    Quantitative data : number of patients, missing data, meanand standard deviation, min-max.

    Between group comparison : Students t-test/Wilcoxon ranksum test (nonparametric)

    Qualitative data : available data, missing data, totalnumbers, percentage

    Comparison adults-children : Chi-square test/exact Fishertest

    Correlation PO-SCORAD SCORAD at D0 and D28 : Bravais-Pearson correlation coefficient

  • 7/30/2019 Journal Reading - Alergi

    10/34

  • 7/30/2019 Journal Reading - Alergi

    11/34

    Resuts

  • 7/30/2019 Journal Reading - Alergi

    12/34

  • 7/30/2019 Journal Reading - Alergi

    13/34

  • 7/30/2019 Journal Reading - Alergi

    14/34

  • 7/30/2019 Journal Reading - Alergi

    15/34

    Discussion

    Validating the ability of PO-SCORAD to self-assess ADseverity

    Confirming the results in pilot study in a large population(75% mild-moderate, 25% severe)

    PO-SCORAD and SCORAD were well correlated

    At D0 : correlation at D0 was good, lower than that assumedin design of the protocol

    Post hoc analysis : both D0 and D28, the correlation betweenSCORAD and PO-SCORAD at D0 was higher [r=0.71 (95%CI:0.64;0.75), p

  • 7/30/2019 Journal Reading - Alergi

    16/34

    Discussion 2nd evaluation: correlation coefficient 0.79

    Learning by doing

    High correlation between absolute changes

    from baseline SCORAD and PO-SCORADPO-SCORAD assess AD accurately

    A valuable tool for doctor gives good estimate

    of AD severity

  • 7/30/2019 Journal Reading - Alergi

    17/34

    Discussion Present study had correlation much stronger

    >> previous study

    Visual explanation

    PO-SCORAD is easy and feasible

    No significant difference between PO-SCORAD

    and SCORAD according to age

  • 7/30/2019 Journal Reading - Alergi

    18/34

    DiscussionPO-

    SCORAD

    Subjective +objective

    Symptomspictures

    POEMscale

    Adequatelyvalidated

    subjectiveoutcome

    SA-EASI

    Itscounterpartfor doctor

    Difficult forpatient

    ADQ

    Poorassessment

    tool

    SkinDetective

    Scale

    Similarwith PO-SCORAD

    Difficult forchildren